kinaseBgamma(PKBgamma/Akt3)inpostnatalbraindevelop-mentbutnotinglucosehomeostasis[J].Development,2005,132(13):2943-2954.[17]IcyuzM,BryantSM,FortinberryHK,etal.Adenovirusinfectionac-tivatesakt1andinducescellproliferationinpancreaticislets1[J].Transplantation,2009,87(6):821-824.[18]LiuY,TanabeK,BaronnierD,etal.ConditionalablationofGsk-3βinisletbetacellsresultsinexpandedmassandresistancetofatfeeding-induceddiabetesinmice[J].Diabetologia,2010,53(12):2600-2610.[19]Velazquez-GarciaS,ValleS,RosaTC,etal.ActivationofproteinkinaseC-ζinpancreaticβ-cellsinvivoimprovesglucosetoleranceandinducesβ-cellexpansionviamTORactivation[J].Diabetes,2011,60(10):2546-2559.[20]UchidaT,NakamuraT,HashimotoN,etal.DeletionofCdkn1ba-meliorateshyperglycemiabymaintainingcompensatoryhyperinsu-linemiaindiabeticmice[J].NatMed,2005,11(2):175-182.[21]JohnsonJD,AhmedNT,LucianiDS,etal.IncreasedisletapoptosisinPdx1+/-mice[J].JClinInvest,2003,111(8):1147-1160.[22]KluthO,MirhashemiF,ScherneckS,etal.Dissociationoflipotox-icityandglucotoxicityinamousemodelofobesityassociateddia-betes:roleofforkheadboxO1(FOXO1)inglucose-inducedbetacellfailure[J].Diabetologia,2011,54(3):605-616.[23]VenieratosPD,DrossopoulouGI,KapodistriaKD,etal.Highglu-coseinducessuppressionofinsulinsignallingandapoptosisviaup-regulationofendogenousIL-1betaandsuppressorofcytokinesig-nalling-1inmousepancreaticbetacells[J].CellSignal,2010,22(5):791-800.[24]HarbeckMC,LouieDC,HowlandJ,etal.Expressionofinsulinre-ceptormRNAandinsulinreceptorsubstrate1inpancreaticisletbeta-cells[J].Diabetes,1996,45(6):711-717.[25]AssmannA,UekiK,WinnayJN,etal.Glucoseeffectsonbeta-cellgrowthandsurvivalrequireactivationofinsulinreceptorsandinsulinreceptorsubstrate2[J].MolCellBiol,2009,29(11):3219-3228.[26]NiessenM.OntheroleofIRS2intheregulationoffunctionalbeta-cellmass[J].ArchPhysiolBiochem,2006,112(2):65-73.[27]Al-MasriM,KrishnamurthyM,LiJ,etal.EffectofforkheadboxO1(FOXO1)onbetacelldevelopmentinthehumanfetalpancreas[J].Diabetologia,2010,53(4):699-711.[28]FanR,LiX,GuX,etal.Exendin-4protectspancreaticbetacellsfromhumanisletamyloidpolypeptide-inducedcelldamage:poten-tialinvolvementofAKTandmitochondriabiogenesis[J].DiabetesObesMetab,2010,12(9):815-824.[29]RaoP,RoccisanaJ,TakaneKK,etal.Genetransferofconstitutive-lyactiveAktmarkedlyimproveshumanislettransplantoutcomesindiabeticseverecombinedimmunodeficientmice[J].Diabetes,2005,54(6):1664-1675.收稿日期:2011-09-26修回日期:2011-12-06编辑:潘雪雌激素与动脉粥样硬化刘欣1△(综述),殷惠军2※(审校)(1.北京中医药大学,北京100029;2.中国中医科学院西苑医院心血管实验室,北京100091)中图分类号:R543.5;R34文献标识码:A文章编号:1006-2084(2012)08-1124-04基金项目:国家自然科学基金(81173584)摘要:雌激素用来防治动脉粥样硬化(AS)已经成为近年来的热点。研究表明,雌激素抗AS的机制大多与其对血管内皮、血管平滑肌、血脂的调节及抗凝血等作用有关。AS的免疫-炎症理论为研究抗AS的机制提供了新的思路。雌激素替代疗法尚存在争议,植物类雌激素及中药复方类雌激素应用逐渐被人们所重视。现就雌激素与AS关系的研究进行综述。关键词:雌激素;动脉粥样硬化;信号转导EstrogenandAtherosclerosisLIUXin1,YINHui-jun2.(1.BejingUniversityofChineseMedicine,Beijing100029,China;2.DepartmentofCardiovascularDiseasesXiyuanHospitalofChinaAcademyofChineseMedicalSciences,Beijing100091,China)Abstract:Themechanismofestrogentopreventandtreatatherosclerosis(AS)hasbecomethehotspotinrecentyears.Researchhasshownthatresista...